Pfizer Medicare Part D Negotiations Not Focusing On Dual-Eligible Plans
Executive Summary
Pfizer is not prioritizing preferred tier positioning in negotiations with Medicare Part D drug plans expected to enroll large numbers of dual-eligibles due to the limited difference in brand tier copays for such beneficiaries